Help
Posted Thu, Mar, 29,2012
Libertas Academica has been using Twitter since February 2010 to benefit readers and authors.
As a reader, by following Lymphoma and Chronic Lymphocytic Leukemias on Twitter you will be notified about new articles in your field of expertise, calls for papers, Editorial announcements, and any other important updates for the journal.
We post on Twitter within minutes of a paper being published so Twitter followers are the first people to view new articles.
For authors our Twitter services offer your article even greater visibility. Libertas Academica uses Twitter because it’s visibility and popularity gives us the opportunity to inform thousands of people about new articles published.
Visit the Lymphoma and Chronic Lymphocytic Leukemias Twitter feed
What is Twitter?
Twitter is one of the most popular and user-friendly social media sites on the internet.
By following Lymphoma and Chronic Lymphocytic Leukemias on Twitter, you can receive e-mail, SMS and website notifications of new articles and other important updates.
We make sure that readers are kept up to date with the latest news and publications for all of our journals, and can reach over 7,000 Twitter subscribers.
See our full list of Twitter services
Posted in: Social Media
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesI find Ophthalmology and Eye Diseases very author-friendly. As a first time author publishing in this journal I experienced close attention to authors, prompt and close co-operation in all phases of production of my manuscript encouraging. Your excellent staff simplified a daunting process that often makes authors just give up on publication due to unwarranted and irrational complexities, with close guidance to produce high quality work.
Facebook Google+ Twitter
Pinterest Tumblr YouTube